Test Bank for Advanced Pharmacology for
x x x x x x
Prescribers 1st Edition Luu Kayingo complete
x x x x x xx
guide with rationale
x x x
, Table of Contents x x
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................. 3
x x x x x x x x
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
x x x x
Chapter4: Pharmacogenetics and Pharmacogenomics ................................................................................ 25
x x x
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
x x x x x x
Chapter 6: Drug-Therapy Prescribing in Special Populations.................................................................... 36
x x x x x x
Chapter 7: Drug Development and Approval ............................................................................................ 45
x x x x x
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
x x x x x x x x x
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
x x x x x x
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
x x x x x
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
x x x x x x x x x
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapte
x x x x x x x x x x x
xr 14: Pharmacotherapy for Eye Conditions ................................................................................................ 67
x x x x x
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................... 74
x x x x x
Chapter 16: Pharmacotherapy for Neurologic Conditions ......................................................................... 81
x x x x x
Chapter 17: Pharmacotherapy for Cardiovascular Conditions .................................................................. 94
x x x x x
Chapter 18: Pharmacotherapy for Respiratory Conditions ...................................................................... 106
x x x x x
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Supp
x x x x x x x x x
ort .............................................................................................................................................................. 117
x
Chapter 20: Pharmacotherapy for Genitourinary Conditions................................................................... 128
x x x x x
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ......................... 133
x x x x x x x x x
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions .............................. 146
x x x x x x x
Chapter 23: Therapeutic Applications of Immunology and Vaccines .................................................... 158
x x x x x x x
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
x x x x x
Chapter 25: Pharmacotherapy for Hematologic Disorders....................................................................... 174
x x x x x
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................... 190
x x x x x x x x
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................................. 196
x x x x x x x
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ....................................................... 211
x x x x x x x
Chapter 29: Pharmacotherapy Related to Transgender Care .................................................................. 217
x x x x x x
Chapter 30: Antimicrobial Pharmacotherapy............................................................................................ 224
x x x
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................ 235
x x x
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuro
x x x x x x x x x x
cognitive Conditions ................................................................................................................................. 247
x x
Chapter 33: Pharmacotherapy for Pain Management .............................................................................. 257
x x x x x
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ....................................... 267
x x x x x x x x x
Chapter 35: Over-the-Counter Medications.............................................................................................. 283
x x x
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
x x x x
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
x x x x x x x x
MULTIPLE CHOICE x
• What is the primary purpose of the nursing assessment?
x x x x x x x x
A. Identifying underlying pathologic conditions x x x
B. Assisting the physician in identifying medical conditions x x x x x x
C. Determining the patients mental status x x x x
D. Exploring patient responses to health problems x x x x x
ANS: D x
A nursing assessment is done to identify the patients response to health pr
x x x x x x x x x x x x
oblems. During the nursing assessment phase, a comprehensive informati
x x x x x x x x x
on base is developed through a physical examination, nursing history, me
x x x x x x x x x x x
dication history, and professional observation. Identifying underlying path
x x x x x x x x
ologic conditions and assisting the physician in identifying medical condit
x x x x x x x x x x
ions is not part of the nursing process. Determining the patients mental st
x x x x x x x x x x x x x
atus is one part of the nursing assessment, but it is not the primary
x x x x x x x x x x x x x x
purp ose.
x x
DIF: Cognitive Level: Comprehension
x x x
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
x x x x x x x x x
Process Step: Assessment
x x x
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
x x x x x x x x
• What is the basis of the NANDA I taxonomy?
x x x x x x x x
A. Functional health patterns x x
B. Human response patterns x x
C. Basic human needs x x
D. Pathophysiologic needs x
ANS: B x
The NANDA I taxonomy identifies human response patterns.
x x x x x x x
Functio nal components of health patterns are limited to activity, fluid
x x x x x x x x x x x
volume, n utrition, self care, and sensory perception. Basic human needs
x x x x x x x x x x x
comprise l ess than merely health patterns. Pathophysiologic needs are
x x x x x x x x x x
not part of t he scope of NANDA I.
x x x x x x x x x
, DIF: Cognitive Level: Knowledge RE
x x x x
F: pp. 37-38 OBJ: 5 TOP:
x x x x x x
Nursing Process Step: Diagnosis x x x
MSC: NCLEX Client Needs Category: Physiological Integrity
x x x x x x
• Which task is included in the assessment step of the nursing process?
x x x x x x x x x x x
A. Establishing patient goals/outcomes x x
B. Implementing the nursing care plan (NCP) x x x x x
C. Measuring goal/outcome achievement x x
D. Collecting and communicating data x x x
ANS:RD
Data are collected and communicated in the assessment phase of the nursi
x x x x x x x x x x x
ng process. Establishing goals is the function of planning.
x x x x x x x x x
Implementing the NCP is the function of implementation. Measuring outc x x x x x x x x x
ome achievement is the function of evaluation.
x x x x x x x
DIF: Cognitive Level: Comprehension
x x x
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
x x x x x x x x x
Process Step: Assessment
x x x
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
x x x x x x x x
• Which statement regarding nursing diagnoses is accurate?
x x x x x x
a. Nursing diagnoses remain the same for as long as the disease is present. x x x x x x x x x x x x
b. Nursing diagnoses are written to identify disease states. x x x x x x x
c. Nursing diagnoses describe patient problems that nurses treat. x x x x x x x
d. Nursing diagnoses identify causes related to illness. x x x x x x
ANS: C x
Diagnostic statements identify problems a nurse is independently able to
x x x x x x x x x
treat within the scope of professional practice. Nursing diagnoses vary wi
x x x x x x x x x x x
th the changing condition of the patient. The response patterns are unique
x x x x x x x x x x x x
to the patient and are not disease specific. Nursing diagnoses describe th
x x x x x x x x x x x x
xe patients human response pattern.
x x x x
DIF: Cognitive Level: Comprehension
x x x
x x x x x x
Prescribers 1st Edition Luu Kayingo complete
x x x x x xx
guide with rationale
x x x
, Table of Contents x x
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................. 3
x x x x x x x x
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
x x x x
Chapter4: Pharmacogenetics and Pharmacogenomics ................................................................................ 25
x x x
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
x x x x x x
Chapter 6: Drug-Therapy Prescribing in Special Populations.................................................................... 36
x x x x x x
Chapter 7: Drug Development and Approval ............................................................................................ 45
x x x x x
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
x x x x x x x x x
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
x x x x x x
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
x x x x x
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
x x x x x x x x x
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapte
x x x x x x x x x x x
xr 14: Pharmacotherapy for Eye Conditions ................................................................................................ 67
x x x x x
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................... 74
x x x x x
Chapter 16: Pharmacotherapy for Neurologic Conditions ......................................................................... 81
x x x x x
Chapter 17: Pharmacotherapy for Cardiovascular Conditions .................................................................. 94
x x x x x
Chapter 18: Pharmacotherapy for Respiratory Conditions ...................................................................... 106
x x x x x
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Supp
x x x x x x x x x
ort .............................................................................................................................................................. 117
x
Chapter 20: Pharmacotherapy for Genitourinary Conditions................................................................... 128
x x x x x
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ......................... 133
x x x x x x x x x
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions .............................. 146
x x x x x x x
Chapter 23: Therapeutic Applications of Immunology and Vaccines .................................................... 158
x x x x x x x
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
x x x x x
Chapter 25: Pharmacotherapy for Hematologic Disorders....................................................................... 174
x x x x x
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................... 190
x x x x x x x x
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................................. 196
x x x x x x x
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ....................................................... 211
x x x x x x x
Chapter 29: Pharmacotherapy Related to Transgender Care .................................................................. 217
x x x x x x
Chapter 30: Antimicrobial Pharmacotherapy............................................................................................ 224
x x x
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................ 235
x x x
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuro
x x x x x x x x x x
cognitive Conditions ................................................................................................................................. 247
x x
Chapter 33: Pharmacotherapy for Pain Management .............................................................................. 257
x x x x x
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ....................................... 267
x x x x x x x x x
Chapter 35: Over-the-Counter Medications.............................................................................................. 283
x x x
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
x x x x
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
x x x x x x x x
MULTIPLE CHOICE x
• What is the primary purpose of the nursing assessment?
x x x x x x x x
A. Identifying underlying pathologic conditions x x x
B. Assisting the physician in identifying medical conditions x x x x x x
C. Determining the patients mental status x x x x
D. Exploring patient responses to health problems x x x x x
ANS: D x
A nursing assessment is done to identify the patients response to health pr
x x x x x x x x x x x x
oblems. During the nursing assessment phase, a comprehensive informati
x x x x x x x x x
on base is developed through a physical examination, nursing history, me
x x x x x x x x x x x
dication history, and professional observation. Identifying underlying path
x x x x x x x x
ologic conditions and assisting the physician in identifying medical condit
x x x x x x x x x x
ions is not part of the nursing process. Determining the patients mental st
x x x x x x x x x x x x x
atus is one part of the nursing assessment, but it is not the primary
x x x x x x x x x x x x x x
purp ose.
x x
DIF: Cognitive Level: Comprehension
x x x
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
x x x x x x x x x
Process Step: Assessment
x x x
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
x x x x x x x x
• What is the basis of the NANDA I taxonomy?
x x x x x x x x
A. Functional health patterns x x
B. Human response patterns x x
C. Basic human needs x x
D. Pathophysiologic needs x
ANS: B x
The NANDA I taxonomy identifies human response patterns.
x x x x x x x
Functio nal components of health patterns are limited to activity, fluid
x x x x x x x x x x x
volume, n utrition, self care, and sensory perception. Basic human needs
x x x x x x x x x x x
comprise l ess than merely health patterns. Pathophysiologic needs are
x x x x x x x x x x
not part of t he scope of NANDA I.
x x x x x x x x x
, DIF: Cognitive Level: Knowledge RE
x x x x
F: pp. 37-38 OBJ: 5 TOP:
x x x x x x
Nursing Process Step: Diagnosis x x x
MSC: NCLEX Client Needs Category: Physiological Integrity
x x x x x x
• Which task is included in the assessment step of the nursing process?
x x x x x x x x x x x
A. Establishing patient goals/outcomes x x
B. Implementing the nursing care plan (NCP) x x x x x
C. Measuring goal/outcome achievement x x
D. Collecting and communicating data x x x
ANS:RD
Data are collected and communicated in the assessment phase of the nursi
x x x x x x x x x x x
ng process. Establishing goals is the function of planning.
x x x x x x x x x
Implementing the NCP is the function of implementation. Measuring outc x x x x x x x x x
ome achievement is the function of evaluation.
x x x x x x x
DIF: Cognitive Level: Comprehension
x x x
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
x x x x x x x x x
Process Step: Assessment
x x x
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
x x x x x x x x
• Which statement regarding nursing diagnoses is accurate?
x x x x x x
a. Nursing diagnoses remain the same for as long as the disease is present. x x x x x x x x x x x x
b. Nursing diagnoses are written to identify disease states. x x x x x x x
c. Nursing diagnoses describe patient problems that nurses treat. x x x x x x x
d. Nursing diagnoses identify causes related to illness. x x x x x x
ANS: C x
Diagnostic statements identify problems a nurse is independently able to
x x x x x x x x x
treat within the scope of professional practice. Nursing diagnoses vary wi
x x x x x x x x x x x
th the changing condition of the patient. The response patterns are unique
x x x x x x x x x x x x
to the patient and are not disease specific. Nursing diagnoses describe th
x x x x x x x x x x x x
xe patients human response pattern.
x x x x
DIF: Cognitive Level: Comprehension
x x x
